Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RWJ-445380 in Active Rheumatoid Arthritis Despite Methotrexate
NCT00425321Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of RWJ-445380 in rheumatoid arthritis (RA), sponsored by Johnson & Johnson. Started Dec 2006; status: completed.
02
Drugs
RWJ-445380
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00425321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425321.